BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22221260)

  • 21. Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?
    Wenzel RG; Tepper S; Korab WE; Freitag F
    Ann Pharmacother; 2008 Nov; 42(11):1692-6. PubMed ID: 18957623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Serotonin "Cocktail".
    Nunes JC; Botas JL
    Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32628370
    [No Abstract]   [Full Text] [Related]  

  • 23. From the editorial office.
    Rothrock JF
    Headache; 2012; 52(7):1069. PubMed ID: 22755549
    [No Abstract]   [Full Text] [Related]  

  • 24. Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome.
    Sclar DA; Robison LM; Skaer TL
    Headache; 2008 Jan; 48(1):126-9. PubMed ID: 18005139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible mild serotonin syndrome related to co-prescription of tandospirone and trazodone.
    Kaneda Y; Ohmori T; Okabe H
    Gen Hosp Psychiatry; 2001; 23(2):98-101. PubMed ID: 11354048
    [No Abstract]   [Full Text] [Related]  

  • 26. Is an FDA alert harming patients?
    Schuman E
    JAAPA; 2009 May; 22(5):55. PubMed ID: 19469393
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of Serotonin Syndrome With Combined Use of Linezolid and Serotonin Reuptake Inhibitors Compared With Linezolid Monotherapy.
    Karkow DC; Kauer JF; Ernst EJ
    J Clin Psychopharmacol; 2017 Oct; 37(5):518-523. PubMed ID: 28796019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the 5-HT system: Potential side effects.
    Hoyer D
    Neuropharmacology; 2020 Nov; 179():108233. PubMed ID: 32805212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case of an Older Adult Patient and Drugs Associated with Serotonin Syndrome.
    Nguyen T; Sin B
    Consult Pharm; 2015 Aug; 30(8):455-8. PubMed ID: 26260641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is There Always a Right or Wrong?: Comments on the FDA Warnings About Triptans and the Serotonin Syndrome.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 2018 Dec; 38(6):545-546. PubMed ID: 30303862
    [No Abstract]   [Full Text] [Related]  

  • 31. Triptans in pregnancy.
    Soldin OP; Dahlin J; O'Mara DM
    Ther Drug Monit; 2008 Feb; 30(1):5-9. PubMed ID: 18223456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do triptans increase the risk of thromboembolic stroke?
    Archambault ME
    JAAPA; 2006 Jul; 19(7):57-8. PubMed ID: 16869155
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible serotonin syndrome associated with buspirone added to fluoxetine.
    Manos GH
    Ann Pharmacother; 2000; 34(7-8):871-4. PubMed ID: 10928399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience using appetite suppressants and SSRIs.
    Rader WA; Steelman GM; Westman EC
    J Okla State Med Assoc; 2008 Aug; 101(8):180-1. PubMed ID: 18777796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination of serotonergic agents resulted in severe adverse effects].
    Jägestedt M; von Bahr C
    Lakartidningen; 2004 Apr; 101(18):1618-9. PubMed ID: 15185539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain.
    Li J; Lu C; Gao Z; Feng Y; Luo H; Lu T; Sun X; Hu J; Luo Y
    Neuropharmacology; 2020 Oct; 177():108237. PubMed ID: 32710978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose.
    Little K; Lin CM; Reynolds PM
    Am J Case Rep; 2018 May; 19():604-607. PubMed ID: 29795058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors as adjuncts for postoperative pain management: systematic review and meta-analysis of randomised controlled trials.
    Wang L; Tobe J; Au E; Tran C; Jomy J; Oparin Y; Couban RJ; Paul J
    Br J Anaesth; 2022 Jan; 128(1):118-134. PubMed ID: 34756632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case Report: Rizatriptan-Induced Ischemic Colitis.
    Fonseka GR; Kurchin A
    Headache; 2015; 55(7):1008-9. PubMed ID: 25881718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.